查看完整行情页>>

|

货币单位:美元(USD)

CoreSite房产

Cencora, Inc. (cor)

实时(?):
盘后(?):
读取中...
  • -- (--%)
开盘价:-- 最高价:-- 最低价:-- 52周最高价:-- 52周最低价:--
成交量:-- 平均成交量:-- 市值:-- 市盈率:-- 预期市盈率:--
每股收益:-- 贝塔系数:-- 股息:-- 收益率:-- 总股本:--
Robert P. Mauch Robert P. Mauch is the founder of Xcenda LLC. He currently holds the position of Chairman at Healthcare Distribution Alliance and Chairman at Covenant House, Inc. Additionally, he is the Chief Operating Officer & Executive Vice President at Cencora, Inc. since 2015. He is also a Member of the American Pharmacists Association and the International Society for Pharmacoeconomics & Outcomes Research. Previously, he served as President at AmerisourceBergen Drug Corp. from 2015 to 2017. Dr. Mauch holds a doctorate degree from Mercer University and the University of South Carolina.
Lazarus Krikorian Lazarus Krikorian is currently working as the Chief Accounting Officer & Senior Vice President at Cencora, Inc. He started this position in 2012. Prior to his current role, Lazarus worked as a Senior Assurance Manager at KPMG LLP. Lazarus completed his undergraduate degree at Drexel University.
James Francis Cleary James Francis Cleary is currently a Director at Centaur Services Ltd., Labpak Ltd., MWI Veterinary Supply Co., MWI Supply (UK Acquisition) Ltd., Vetswest Ltd., St. Francis Ltd., MWI Supply (UK Holdings) Ltd., and a Member-Board of Managers at Feeders' Advantage LLC. He was formerly the President, Chief Executive Officer & Director at MWI Veterinary Supply, Inc. from 1997 to 2015, and the President & Chief Executive Officer at MWI Veterinary Supply Co. from 2002 to 2017. He also held positions as Director at Profarma Distribuidora de Produtos Farmaceuticos SA, Agri Beef Co., and Seroyal Holdings LP. Mr. Cleary received his undergraduate degree from Dartmouth College in 1985 and his MBA from Harvard Business School in 1990.
Silvana Battaglia Silvana Battaglia is an Independent Director at Agilon Health, Inc. and the Chief Human Resources Officer & Executive VP at Cencora, Inc. She previously worked as the Director-Human Resources at Merck & Co., Inc. from 1998 to 2008, and as the Senior Vice President-Human Resources at The Day & Zimmermann Group, Inc. from 2008 to 2011. She was also a Senior VP-Global Compensation & Benefits at Aramark from 2017 to 2019. Battaglia is a member of St. Joseph's University. She received her undergraduate degree from Temple University (Pennsylvania) and her graduate degree from Widener University.
Steven H. Collis Steven H. Collis is currently the Chairman, President & Chief Executive Officer at Cencora, Inc. He is also the Vice Chairman at The Kennedy Center Corporate Fund. Additionally, he serves as a Director at MWI Veterinary Supply, Inc., the International Federation of Pharmaceutical Wholesalers, and the American Cancer Society's CEOs Against Cancer. He is a Member-Governors Board at The American National Red Cross. Previously, Mr. Collis held the position of Chief Executive Officer at Bellco Drug Corp. He was an Independent Director at Thoratec Corp. from 2013 to 2015. He served as the President-Specialty Group at Bergen Brunswig Corp. and as the General Manager at ASD Specialty Healthcare LLC and Sterling Medical Services LLC. He was also a Member of the Johannesburg Stock Exchange. He held the position of President & Executive Vice President at AmerisourceBergen Specialty Group LLC from 2007 to 2009, and later became the President of AmerisourceBergen Drug Corp. from 2010 to 2011. Mr. Collis completed his undergraduate and graduate degrees at the University of the Witwatersrand.
Jennifer E. Dubas Jennifer E. Dubas is currently the Chief Compliance Officer & Senior Vice President at Cencora, Inc. She previously worked as In-House Counsel at Wyeth LLC and Pfizer Inc. and as Vice President & Chief Compliance Officer at Endo International Plc. Ms. Dubas received her undergraduate degree from Bryn Mawr College and her graduate degree from Temple University Beasley School of Law.
Leslie E. Donato Leslie E. Donato is currently the Director at OneOncology LLC and a Trustee at Virtua Health, Inc. She is also the Chief Strategy Officer & Executive Vice President at Cencora, Inc. Leslie's former jobs include being the Vice President & GM-Neurology & Hematology at Bayer Pharmaceuticals Corp. and a Partner & Principal at McKinsey & Co., Inc. She completed her undergraduate degree at Swarthmore College and earned an MBA from The Wharton School of the University of Pennsylvania.
Elizabeth S. Campbell Elizabeth S. Campbell is the founder of McCaskill & Co, Inc. (founded in 1999). She is currently working as the Chief Legal Officer & Executive Vice President at Cencora, Inc. (since 2021). Ms. Campbell has a graduate degree from the University of Pittsburgh.
Richard W. Gochnauer Richard W. Gochnauer is currently serving as an Independent Director at Cencora, Inc. since 2008 and as a Director at Golden State Foods Corp. since 1994. He is also a Director at Vodori, Inc., Lead Director at Sc Master Fund LLC, and a Member-Leadership Board at Center For Higher Ambition. In his former positions, Mr. Gochnauer served as the Chief Executive Officer & Director at Essendant, Inc. from 2010 to 2011. He was an Independent Director at UGI Corp. from 2011 to 2020. He also held positions as a Director at UGI Utilities, Inc., Director at Opportunity International, Inc., Director at Fieldstone Communities, LLC from 2000 to 2008, Director at Rush University Medical Center, and Executive Vice President at The Dial Corp. from 1994 to 2002. Mr. Gochnauer holds an MBA from Harvard University and an undergraduate degree from Northwestern University.
Kathleen W. Hyle Kathleen W. Hyle is currently the Chairman at Bunge Netherlands BV. She is also an Independent Director at Cencora, Inc., a Director at X-Energy Reactor Co. LLC, an Independent Director at X-Energy, Inc., a Trustee at Center Stage Associates, Inc. (Maryland), and a Member at Wkw LLC. In her former positions, Ms. Hyle served as the Non-Executive Chairman at Bunge Ltd. from 2012 to 2023. She was also a Director at The ADT Security Corp. from 2012 to 2016. Additionally, she held positions as a Director at MXenergy Holdings, Inc., ADT, Inc. (Pennsylvania), and The Black & Decker Corp. She served as the Treasurer & Vice President at AutoNation, Inc. and ANC Rental Corp., as well as the Chief Financial Officer at National Car Rental System, Inc. Ms. Hyle was the Senior Vice President-Finance at Constellation Energy Group, Inc. from 2005 to 2007 and the Senior VP-Finance, Information Technology & Risk at Constellation NewEnergy, Inc. in 2005. She also served as the Chief Operating Officer at Constellation Energy Resources LLC from 2008 to 2012. Ms. Hyle was the Chief Financial Officer at UniStar Nuclear Energy LLC and Constellation Energy Nuclear Group LLC in 2007 and 2008, respectively. She held the position of Treasurer & Vice President at Stanley Black & Decker, Inc. and was a Trustee at Sellinger School of Business & Management. Ms. Hyle obtained her undergraduate degree from Loyola University Maryland, Inc.
D. Mark Durcan D. Mark Durcan is currently serving as the Chairman of Micron Technology Foundation, Inc. He is also an Independent Director at Advanced Micro Devices, Inc., Lead Independent Director at Cencora, Inc., Director at Advanced Micro Devices (Singapore) Pte Ltd., Director at St. Luke's Health System Ltd., Director at MP Mask Technology Center LLC, Director at EUV LLC, Director at Natural Intelligence Systems, Inc., Member-Supervisory Board at ASML Holding NV, and Trustee at Rice University. In his former positions, Mr. Durcan served as the Chief Executive Officer & Director of Micron Technology, Inc. from 2012 to 2017. He also held the position of Vice Chairman at Micron Technology Taiwan, Inc. Additionally, he served as a Director at Freescale Semiconductor, Inc., MWI Veterinary Supply, Inc., and Freescale Semiconductor Ltd. He was a Director at Technology Ceo Council and Micron Technology Utah LLC. Furthermore, he served as a Director at Semiconductor Industry Association from 2011 to 2017 and as an Independent Director at Arriver Holdco, Inc. from 2018 to 2022. Mr. Durcan completed his undergraduate and graduate degrees at Rice University.
Lauren M. Tyler Lauren M. Tyler is an Independent Director at Cencora, Inc. since 2023. Previously, she was an Independent Director at Alleghany Corp. from 2019 to 2022. She also held positions as a Director at TSG Capital Group LLC, Global Chief Auditor at JPMorgan Chase & Co. from 2011 to 2014, Partner at J.P. Morgan Partners LLC in 2005-2006, Partner at CCMP Capital Advisors LP in 2006-2007, and Managing Member at Quetzal from 2005 to 2008. Ms. Tyler holds an MBA from Harvard University and an undergraduate degree from Yale University.
Werner Baumann Werner Baumann currently holds four director positions at Cencora, Inc., Pharmaceutical Research & Manufacturers of America, Bayer CropScience NV, and Verband der Chemischen Industrie eV. Previously, he served as the Chairman-Management Board & CEO of Bayer AG from 2016 to 2023, Chairman-Management Board of Bayer HealthCare AG in 2015, and Chairman-Supervisory Board of Bayer Business Services GmbH from 2011 to 2014. He also held various other positions at Bayer AG, including Head-Global Business Planning & Administration at Bayer Corp. and Controller at Bayer Hispania SL. Baumann received his undergraduate degree from Universität zu Köln and RWTH Aachen University.
Dennis M. Nally Dennis M. Nally is currently the Vice Chairman of the United States Council for International Business, Vice Chairman of The HOW Institute For Society, Independent Director at Morgan Stanley and Cencora, Inc., Director at Globality, Inc., Member of The American Institute of Certified Public Accountants and New York State Society of Certified Public Accountants, and Trustee of The Carnegie Hall Corp. Previously, he was the Chairman of PricewaterhouseCoopers LLP and PricewaterhouseCoopers International Ltd. from 2009 to 2016. He was also a Director of The Partnership for New York City, Inc. and a Trustee of The Carnegie Hall Society, Inc. He received his undergraduate degree from Western Michigan University.
Lorence H. Kim Lorence H. Kim is the founder of Ascenta Capital, which was founded in 2023. He is currently an Independent Director at Cencora, Inc., Cowen, Inc., Revolution Medicines, Inc., and ADARx Pharmaceuticals, Inc. He is also a Director at Flare Therapeutics, Inc. and Abata Therapeutics, Inc. Dr. Kim is a Trustee at Prep for Prep and a Member-Governors Board at American Red Cross, Inc. In the past, he held the position of Chief Financial Officer at ModernaTX, Inc. from 2014 to the present. Prior to that, he worked as a Managing Director at Goldman Sachs & Co. LLC from 1999 to 2014. He was also an Independent Director at Cowen, Inc. from 2022 to 2023, an Independent Director at Seres Therapeutics, Inc. from 2014 to 2020, and a Venture Partner at Third Rock Ventures LLC from 2020 to 2022. Dr. Kim received his undergraduate degree from Harvard University in 1995. He also holds an MBA from The Wharton School of the University of Pennsylvania, a doctorate from Perelman School of Medicine, and a doctorate from the University of Pennsylvania School of Veterinary Medicine.
Redonda G. Miller Redonda G. Miller is currently an Independent Director at Cencora, Inc., a Director at The Johns Hopkins Home Care Group, Inc., a Director at Gilchrist Hospice Care, Inc., a Director at Turnaround Tuesday, Inc., and a Trustee at Calvert School, Inc. Previously, she served as the President of The Johns Hopkins Hospital, Inc. starting in 2004 and as an Associate Professor at The Johns Hopkins University starting in 2006. She also held the position of Director at Invivyd, Inc. from 2021 to 2022. Dr. Miller has an MBA from The Johns Hopkins University, an undergraduate degree from The Ohio State University, and a doctorate from The Johns Hopkins University School of Medicine.
Lon R. Greenberg Lon R. Greenberg is currently the Chairman at AGZ Holding SAS since 2004, Chairman at The Philadelphia Foundation since 2017, Independent Director at Cencora, Inc. since 2013, and Director at Greater Philadelphia Chamber of Commerce. Previously, he served as Chairman & Chief Executive Officer at UGI Corp. from 1980 to 2016, Non-Executive Chairman at AmeriGas Partners LP from 1994 to 2016, Chairman at UGI Utilities, Inc. from 1996 to 2016, Non-Executive Chairman at AmeriGas Propane, Inc. from 1994 to 2016, Chairman at Temple University Health System, Inc., Vice Chairman at United Way of Greater Philadelphia & Southern New Jersey from 2012 to 2015, Chairman at Pennsylvania Business Council, Independent Director at Essential Utilities, Inc. from 2005 to 2017, Director at The Fox Chase Cancer Center, Director at Reading Is Fundamental, Inc., Independent Director at Ameriprise Financial, Inc. from 2011 to 2022, Director at Southern New Jersey Development Council, Director at World LP Gas Association, Vice President & General Counsel at AmeriGas, Inc. from 1984 to 1994, and Attorney at Morgan, Lewis & Bockius LLP. He also served as a Trustee at Temple University (Pennsylvania). Mr. Greenberg obtained his undergraduate degree from The Wharton School of the University of Pennsylvania and his graduate degree from Villanova University School of Law.